Rigel Pharmaceuticals, Inc. (RIGL)
45.16
-0.72
(-1.58%)
USD |
NASDAQ |
Aug 24, 16:00
45.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Shareholders Equity (Quarterly) : 425.42M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 425.42M |
| March 31, 2026 | 399.90M |
| December 31, 2025 | 391.48M |
| September 30, 2025 | 117.61M |
| June 30, 2025 | 81.93M |
| March 31, 2025 | 18.57M |
| December 31, 2024 | 3.288M |
| September 30, 2024 | -14.64M |
| June 30, 2024 | -29.91M |
| March 31, 2024 | -31.67M |
| December 31, 2023 | -28.64M |
| September 30, 2023 | -31.83M |
| June 30, 2023 | -28.12M |
| March 31, 2023 | -24.26M |
| December 31, 2022 | -13.62M |
| September 30, 2022 | -19.83M |
| June 30, 2022 | -3.677M |
| March 31, 2022 | 6.798M |
| December 31, 2021 | 30.37M |
| September 30, 2021 | 49.67M |
| June 30, 2021 | 68.11M |
| March 31, 2021 | 78.30M |
| December 31, 2020 | 34.03M |
| September 30, 2020 | 50.96M |
| June 30, 2020 | 63.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 78.50M |
| December 31, 2019 | 53.82M |
| September 30, 2019 | 68.91M |
| June 30, 2019 | 78.29M |
| March 31, 2019 | 95.32M |
| December 31, 2018 | 109.88M |
| September 30, 2018 | 103.47M |
| June 30, 2018 | 123.57M |
| March 31, 2018 | 79.81M |
| December 31, 2017 | 100.65M |
| September 30, 2017 | 56.17M |
| June 30, 2017 | 69.60M |
| March 31, 2017 | 84.08M |
| December 31, 2016 | 55.03M |
| September 30, 2016 | 65.94M |
| June 30, 2016 | 73.72M |
| March 31, 2016 | 75.45M |
| December 31, 2015 | 91.38M |
| September 30, 2015 | 96.41M |
| June 30, 2015 | 101.15M |
| March 31, 2015 | 112.15M |
| December 31, 2014 | 128.25M |
| September 30, 2014 | 146.85M |
| June 30, 2014 | 165.73M |
| March 31, 2014 | 188.33M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Cytokinetics, Inc. | -173.49M |
| Perspective Therapeutics, Inc. | 323.86M |
| Capricor Therapeutics, Inc. | 246.22M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 521.07M |
| Total Liabilities (Quarterly) | 95.64M |
| Debt to Equity Ratio | 0.0939 |
| Current Ratio | 1.941 |
| Net Debt Paydown Yield | 0.58% |